Skip to content
drillr.ai
Sign up

CING

Cingulate Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.10
−2.30%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense8.5M9.8M9.4M15.5M9.0M
SG&A Expense16.4M10.2M6.2M7.3M8.5M
General & Admin Expense16.4M10.2M6.2M7.3M8.5M
Selling & Marketing Expense—————
Other Expenses511.0051.00(292.00)(115.00)(562.00)
Total Operating Expenses24.9M19.9M15.6M22.8M17.5M
Cost and Expenses24.9M19.9M15.6M22.8M17.5M
Operating Income (EBIT)(24.9M)(19.9M)(15.6M)(22.8M)(17.5M)
Non-Operating
Interest Income—369.3K—775.8K174.51
Interest Expense(1.2M)924.4K——174.0K
Net Interest Income1.2M(555.2K)—775.8K(173.8K)
Other Non-Op Income/Expense(3.9M)(2.5M)(914.6K)(775.8K)(174.5K)
Non-Operating Income (excl Interest)313.5K(51.00)292.00115.00562.00
EBT (Pre-Tax Income)(28.8M)(22.4M)(16.6M)(23.5M)(17.7M)
Income Tax Expense—————
Bottom Line
Net Income(28.8M)(22.4M)(16.6M)(23.5M)(17.7M)
Earnings from Cont. Ops(28.8M)(22.4M)(16.6M)(23.5M)(17.7M)
Earnings from Discont. Ops—————
Bottom Line Net Income(28.8M)(22.4M)(16.6M)(23.5M)(17.7M)
Per Share
Basic EPS($5.01)($4.13)($10.20)($311.99)($31.20)
Diluted EPS($5.01)($4.13)($10.20)($311.99)($31.20)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding5.4M5.4M3.8M2.3M1.4M
Diluted Shares Outstanding5.4M5.4M3.8M2.3M1.4M
Profitability Metrics
EBITDA194.4M(19.4M)(15.0M)(22.2M)(17.1M)
D&A219.7M540.9K653.1K582.9K394.0K
EBIT(25.2M)(19.9M)(15.6M)(22.8M)(17.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026